Genome wide analysis and clinical correlation of chromosomal and transcriptional mutations in cancers of the biliary tract

Journal of Experimental and Clinical Cancer Research

Volumn 28, Issue 1, 2009, Pages

  Miller, George ^a   Socci, Nicholas D ^b   Dhall, Deepti ^b   D'Angelica, Michael ^b   Dematteo, Ronald P ^b   Allen, Peter J ^b   Singh, Bhuvanesh ^b   Fong, Yuman ^b   Blumgart, Leslie H ^b   Klimstra, David S ^b   Jarnagin, William R ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; COMPLEMENTARY RNA; GENOMIC DNA; RNA; DNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BILIARY TRACT CANCER; CANCER INVASION; CHROMOSOMAL LOCALIZATION; CHROMOSOME 14Q; CHROMOSOME 1P; CHROMOSOME 1Q; CHROMOSOME 20Q; CHROMOSOME 3P; CHROMOSOME 3Q; CHROMOSOME 5P; CHROMOSOME 6Q; CHROMOSOME 7P; CHROMOSOME 7Q; CHROMOSOME 8P; CHROMOSOME 8Q; CHROMOSOME 9P; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GALLBLADDER CANCER; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; GENOME; GENOME WIDE ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BILIARY TRACT TUMOR; CHROMOSOME ABERRATION; DNA MICROARRAY; GENE DOSAGE; GENE EXPRESSION PROFILING; GENETICS; HUMAN CHROMOSOME; HUMAN GENOME; METABOLISM; MIDDLE AGED; MUTATION; NUCLEIC ACID HYBRIDIZATION; PATHOLOGY;

AGED; AGED, 80 AND OVER; BILIARY TRACT NEOPLASMS; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN; DNA, NEOPLASM; FEMALE; GENE DOSAGE; GENE EXPRESSION PROFILING; GENOME, HUMAN; HUMANS; MALE; MIDDLE AGED; MUTATION; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TRANSCRIPTION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 67650742500     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-28-62     Document Type: Article

References (25)

1. Gallbladder carcinoma. G Miller WR Jarnagin, 2008 34 306 312 17964753
2. Gallbladder cancer worldwide: geographical distribution and risk factors. G Randi S Franceschi VC La, Int J Cancer 2006 118 7 1591 602 10.1002/ijc.21683 16397865
3. Risk factors for gallbladder cancer. An international collaborative case-control study. I Serra A Calvo S Baez M Yamamoto K Endoh W Aranda, Cancer 1996 78 7 1515 7 10.1002/(SICI)1097-0142(19961001)78:7<1515::AID-CNCR21>3. 0.CO;2-1 8839560
4. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. WR Jarnagin Y Fong RP DeMatteo M Gonen EC Burke BJ Bodniewicz BAM Youssef D Klimstra LH Blumgart, Ann Surg 2001 234 4 507 17 11573044 10.1097/00000658-200110000-00010
5. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. WR Jarnagin L Ruo SA Little D Klimstra M D'Angelica RP DeMatteo R Wagman LH Blumgart Y Fong, Cancer 2003 98 8 1689 700 10.1002/cncr.11699 14534886
6. Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes. SM Weber WR Jarnagin D Klimstra RP DeMatteo Y Fong LH Blumgart, J Am Coll Surg 2001 193 4 384 91 10.1016/S1072-7515(01)01016-X 11584966
7. Genetic alterations in gallbladder carcinoma. T Kuroki Y Tajima K Matsuo T Kanematsu, Surg Today 2005 35 2 101 5 10.1007/s00595-004-2906-2 15674488
8. K-ras mutation, p53 overexpression, and microsatellite instability in biliary tract cancers: a population-based study in China. A Rashid T Ueki YT Gao PS Houlihan C Wallace BS Wang MC Shen J Deng AW Hsing, Clin Cancer Res 2002 8 10 3156 63 12374683
9. Transforming growth factor beta 1 stimulates vascular endothelial growth factor gene transcription in human cholangiocellular carcinoma cells. C Benckert S Jonas T Cramer MZ Von G Schafer M Peters K Wagner C Radke B Wiedenmann P Neuhaus M Höcker S Rosewicz, Cancer Res 2003 63 5 1083 92 12615726
10. ERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions. K Endo BI Yoon C Pairojkul AJ Demetris AE Sirica, Hepatology 2002 36 2 439 50 10.1053/jhep.2002.34435 12143054
11. Interleukin 6 upregulates myeloid cell leukemia-1 expression through a STAT3 pathway in cholangiocarcinoma cells. H Isomoto S Kobayashi NW Werneburg SF Bronk ME Guicciardi DA Frank GJ Gores, Hepatology 2005 42 6 1329 38 10.1002/hep.20966 16317687
12. Interleukin-6 contributes to Mcl-1 up-regulation and TRAIL resistance via an Akt-signaling pathway in cholangiocarcinoma cells. S Kobayashi NW Werneburg SF Bronk SH Kaufmann GJ Gores, Gastroenterology 2005 128 7 2054 65 10.1053/j.gastro.2005.03.010 15940637
13. Differential cell cycle-regulatory protein expression in biliary tract adenocarcinoma: correlation with anatomic site, pathologic variables, and clinical outcome. WR Jarnagin DS Klimstra M Hezel M Gonen Y Fong K Roggin K Cymes RP DeMatteo M D'Angelica LH Blumgart B Singh, J Clin Oncol 2006 24 7 1152 60 10.1200/JCO.2005.04.6631 16505435
14. Circular binary segmentation for the analysis of array-based DNA copy number data. AB Olshen ES Venkatraman R Lucito M Wigler, Biostatistics 2004 5 4 557 72 10.1093/biostatistics/kxh008 15475419
15. Expression of G1-S modulators (p53, p16, p27, cyclin D1, Rb) and Smad4/Dpc4 in intrahepatic cholangiocarcinoma. YK Kang WH Kim JJ Jang, Hum Pathol 2002 33 9 877 83 10.1053/hupa.2002.127444 12378511
16. Genetic alterations in gallbladder adenoma, dysplasia and carcinoma. YT Kim J Kim YH Jang WJ Lee JK Ryu YK Park SW Kim WH Kim YB Yoon CY Kim, Cancer Lett 2001 169 1 59 68 10.1016/S0304-3835(01)00562-6 11410326
17. Loss of heterozygosity in dysplasia and carcinoma of the gallbladder. HJ Chang SW Kim YT Kim WH Kim, Mod Pathol 1999 12 8 763 9 10463477
18. Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers. K Nakazawa Y Dobashi S Suzuki H Fujii Y Takeda A Ooi, J Pathol 2005 206 3 356 65 10.1002/path.1779 15892172
19. Microsatellite instability in preneoplastic and neoplastic lesions of the gallbladder. JC Roa I Roa P Correa Q Vo JC Araya M Villaseca P Guzmán BG Schneider, J Gastroenterol 2005 40 1 79 86 10.1007/s00535-004-1497-4 15692793
20. Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients. TL Wang LA Diaz Jr K Romans A Bardelli S Saha G Galizia M Choti R Donehower G Parmigiani IeM Shih C Iacobuzio-Donahue KW Kinzler B Vogelstein C Lengauer VE Velculescu, Proc Natl Acad Sci USA 2004 101 9 3089 94 14970324 10.1073/pnas.0308716101
21. Ubiquitin and ubiquitin-like proteins in cancer pathogenesis. D Hoeller CM Hecker I Dikic, Nat Rev Cancer 2006 6 10 776 88 10.1038/nrc1994 16990855
22. Targeting ubiquitin in cancers. I Dikic N Crosetto S Calatroni P Bernasconi, Eur J Cancer 2006 42 18 3095 102 10.1016/j.ejca.2006.05.041 17084074
23. Polymorphisms in the Janus kinase 2 (JAK)/signal transducer and activator of transcription (STAT) genes: putative association of the STAT gene region with familial breast cancer. A Vaclavicek JL Bermejo RK Schmutzler C Sutter B Wappenschmidt A Meindl M Kiechle N Arnold BH Weber D Niederacher B Burwinkel CR Bartram K Hemminki A Försti, Endocr Relat Cancer 2007 14 2 267 77 10.1677/ERC-06-0077 17639043
24. Expression levels of the JAK/STAT pathway in the transition from hormone-sensitive to hormone-refractory prostate cancer. L Tam LM McGlynn P Traynor R Mukherjee JM Bartlett J Edwards, Br J Cancer 2007 97 3 378 83 10.1038/sj.bjc.6603871 17595657
25. Combined inhibition of epidermal growth factor receptor and JAK/STAT pathways results in greater growth inhibition in vitro than single agent therapy. A Dowlati D Nethery JA Kern, Mol Cancer Ther 2004 3 4 459 63 15078989